Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter

Oncogene

Volumn 25, Issue 42, 2006, Pages 5764-5776

  Baillat, D ^a,b   Leprivier, G ^a   Regnier D ^a,c   Vintonenko, N ^a   Begue A ^a   Stehelin D ^a   Aumercier, M ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b WISTAR INSTITUTE   (United States)

^c INSERM   (France)

Author keywords

Ets 1; Gene regulation; MMP 3; Synovial fibroblasts cell transcription

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLIN; MATRIX METALLOPROTEINASE; PALINDROMIC DNA; SMALL INTERFERING RNA; STROMELYSIN; TRANSCRIPTION FACTOR ETS;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER INVASION; CELL LINE; CELL STRAIN HIG 82; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA PURIFICATION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLOMERULONEPHRITIS; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FAMILY; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SYNOVIUM; TRANSACTIVATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN; CYCLOHEXANES; ENZYME ACTIVATION; FATTY ACIDS, UNSATURATED; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; MATRIX METALLOPROTEINASE 3; MICE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-ETS-1; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES;

EID: 33748941411     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209583     Document Type: Article

References (72)

1. Andrews NC, Faller DV. (1991). Nucleic Acids Res 19: 2499.
2. Baillat D, Begue A, Stehelin D, Aumercier M. (2002). J Biol Chem 277: 29386-29398.
3. Barrett JM, Puglia MA, Singh G, Tozer RG. (2002). Breast Cancer Res Treat 72: 227-232.
4. Basuyaux JP, Ferreira E, Stehelin D, Buttice G. (1997). J Biol Chem 272: 26188-26195.
5. Bernier SG, Lazarus DD, Clark E, Doyle B, Labenski MT, Thompson CD et al. (2004). Proc Natl Acad Sci USA 101: 10768-10773.
6. Boyd KE, Wells J, Gutman J, Bartley SM, Farnham PJ. (1998). Proc Natl Acad Sci USA 95: 13887-13892.
7. Buttice G, Kurkinen M. (1993). J Biol Chem 268: 7196-7204.
8. Calmels TP, Mattot V, Wernert N, Vandenbunder B, Stehelin D. (1995). Biol Cell 84: 53-61.
9. Catalano A, Romano M, Robuffo I, Strizzi L, Procopio A. (2001). Am J Pathol 159: 721-731.
10. Chen JH. (1990). Oncogene Res 5: 277-285.
11. Chen YF, Shin SJ, Lin SR. (2005). DNA Cell Biol 24: 126-132.
12. Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B et al. (2002). Arthritis Rheum 46: 1754-1762.
13. Crawford HC, Matrisian LM. (1996). Enzyme Protein 49: 20-37.
14. Datta B, Majumdar A, Datta R, Balusu R. (2004). Biochemistry 43: 14821-14831.
15. Dittmer J, Nordheim A. (1998). Biochim Biophys Acta 1377: F1-11.
16. Frisch SM, Clark EJ, Werb Z. (1987). Proc Natl Acad Sci USA 84: 2600-2604.
17. Frohman MA, Dush MK, Martin GR. (1988). Proc Natl Acad Sci USA 85: 8998-9002.
18. Gaire M, Barro CD, Kerr LD, Carlisle F, Matrisian LM. (1996). Mol Carcinogen 15: 124-133.
19. Galang CK, Der CJ, Hauser CA. (1994). Oncogene 9: 2913-2921.
20. Georgescu HI, Mendelow D, Evans CH. (1988). In Vitro Cell Dev Biol 24: 1015-1022.
21. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M et al. (2002). Clin Cancer Res 8: 3820-3823.
22. Graves BJ, Petersen JM. (1998). Adv Cancer Res 75: 1-55.
23. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. (1995). Oncogene 10: 1461-1463.
24. Hodge DR, Robinson L, Watson D, Lautenberger J, Zhang XK, Venanzoni M et al. (1996). Oncogene 12: 11-18.
25. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H et al. (1990). Nature 348: 555-557.
26. Iwasaka C, Tanaka K, Abe M, Sato Y. (1996). J Cell Physiol 169: 522-531.
27. Kirstein M, Sanz L, Quinones S, Moscat J, Diaz-Meco MT, Saus J. (1996). J Biol Chem 271: 18231-18236.
28. Kria L, Ohira A, Amemiya T. (1998). Curr Eye Res 17: 986-993.
29. Laemmli UK. (1970). Nature 227: 680-685.
30. Lin CW, Robbins PD, Georgescu HI, Evans CH. (1996). Exp Cell Res 223: 117-126.
31. Lowther WT, Matthews BW. (2000). Biochim Biophys Acta 1477: 157-167.
32. Majerus MA, Bibollet-Ruche F, Telliez JB, Wasylyk B, Bailleul B. (1992). Nucleic Acids Res 20: 2699-2703.
33. Malemud CJ, Goldberg VM. (1999). Front Biosci 4: D762-71.
34. Man AK, Young LJ, Tynan JA, Lesperance J, Egeblad M, Werb Z et al. (2003). Mol Cell Biol 23: 8614-8625.
35. Maroulakou IG, Bowe DB. (2000). Oncogene 19: 6432-6442.
36. Mauviel A. (1993). J Cell Biochem 53: 288-295.
37. Mukherjee T, Kumar A, Mathur M, Chattopadhyay TK, Ralhan R. (2003). J Cancer Res Clin Oncol 129: 430-436.
38. Naito T, Razzaque MS, Nazneen A, Liu D, Nihei H, Koji T et al. (2000). J Am Soc Nephrol 11: 2243-2255.
39. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. (2000). J Clin Oncol 18: 1135-1149.
40. Oikawa T, Yamada T. (2003). Gene 303: 11-34.
41. Ozaki I, Mizuta T, Zhao G, Zhang H, Yoshimura T, Kawazoe S et al. (2003). Hepatol Res 27: 289-301.
42. Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S et al. (2002). Oncogene 21: 2309-2319.
43. Pufall MA, Graves BJ. (2002). Annu Rev Cell Dev Biol 18: 421-462.
44. Pufall MA, Lee GM, Nelson ML, Kang HS, Velyvis A, Kay LE et al. (2005). Science 309: 142-145.
45. Quinones S, Buttice G, Kurkinen M. (1994). Biochem J 302(Part 2): 471-477.
46. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE et al. (2005). Nature 436: 123-127.
47. Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Selzer E, Radda I et al. (2001). Arthritis Rheum 44: 266-274.
48. Rekdal C, SjottemE, Johansen T. (2000). J Biol Chem 275: 40288-40300.
49. Rodriguez-Nieto S, Medina MA, Quesada AR. (2001). Anticancer Res 21: 3457-3460.
50. Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N et al. (2004). Cell Mol Life Sci 61: 118-128.
51. Sato Y, Abe M, Tanaka K, Iwasaka C, Oda N, Kanno S et al. (2000). Adv Exp Med Biol 476: 109-115.
52. Sin N, Meng L, Wang MQ, Wen JJ, Bornmann WG, Crews CM. (1997). Proc Natl Acad Sci USA 94: 6099-6103.
53. Singh S, Barrett J, Sakata K, Tozer RG, Singh G. (2002). Curr Drug Targets 3: 359-367.
54. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV et al. (2002). Oncogene 21: 8506-8509.
55. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW et al. (1999). Cell 98: 137-146.
56. Sternlicht MD, Werb Z. (1999) In: T Kreis and R Vale (eds). Guidebook to the Extracellular Matix and Adhesion Proteins. Oxford University Press: New York, pp 505-563.
57. Sun HB, Yokota H. (2001). Bone 28: 303-309.
58. Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K et al. (1999). Circulation 99: 2717-2719.
59. Tokuhara K, Ogata Y, Nakagawa M, Shirouzu K. (2003). Int Surg 88: 25-33.
60. Trojanowska M. (2000). Oncogene 19: 6464-6471.
61. Vetter M, Blumenthal SG, Lindemann RK, Manns J, Wesselborg S, Thomssen C et al. (2005). Oncogene 24: 650-661.
62. Vu TH, Werb Z. (2000). Genes Dev 14: 2123-2133.
63. Wakiya K, Begue A, Stehelin D, Shibuya M. (1996). J Biol Chem 271: 30823-30828.
64. Wang J, Lou P, Henkin J. (2000). J Cell Biochem 77: 465-473.
65. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. (1991). EMBO J 10: 1127-1134.
66. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C et al. (1994). Cancer Res 54: 5683-5688.
67. Wernert N, Stanjek A, Kiriakidis S, Hugel A, Jha HC, Mazitschek R et al. (1999). Angew Chem Int Ed Engl 38: 3228-3231.
68. Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW et al. (1998). Genes Dev 12: 1315-1326.
69. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ et al. (1996). Mol Cell Biol 16: 538-547.
70. Ye S, Whatling C, Watkins H, Henney A. (1999). FEBS Lett 450: 268-272.
71. Zhang Y, Griffith EC, Sage J, Jacks T, Liu JO. (2000). Proc Natl Acad Sci USA 97: 6427-6432.
72. Zucker S, Cao J, Chen WT. (2000). Oncogene 19: 6642-6650.